| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/02/2010 | US7670601 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders |
| 03/02/2010 | US7670599 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy |
| 03/02/2010 | US7670597 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 02/25/2010 | WO2010022236A2 Inhibiting obesity progression by inhibiting adipocyte differentiation with a pre-adipocyte autophagy inhibitor |
| 02/25/2010 | WO2010022198A2 T cell receptors and related materials and methods of use |
| 02/25/2010 | WO2010022143A2 Assessing and treating breast cancer patients |
| 02/25/2010 | WO2010021770A1 Heterogeneous polymeric micelles for intracellular delivery |
| 02/25/2010 | WO2010021415A1 Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase |
| 02/25/2010 | WO2010021389A1 Nucleic acid capable of inhibiting expression of bcl-2 protein |
| 02/25/2010 | WO2010020822A1 Therapy for apolipoprotein-induced hypertriglyceridemia |
| 02/25/2010 | WO2010020694A1 Polynucleotides which down-regulate the expression of the sbi protein |
| 02/25/2010 | WO2010020682A1 Production of n-acylated sulphur-containing amino acids with microorganisms having enhanced n-acyltransferase enzymatic activity |
| 02/25/2010 | WO2009140429A3 Micellic assemblies |
| 02/25/2010 | WO2009140421A3 Polymeric carrier |
| 02/25/2010 | WO2009137795A3 Methods for treating endoplasmic reticulum (er) stress disorders |
| 02/25/2010 | WO2009126308A3 Compositions and methods for vaccine and virus production |
| 02/25/2010 | WO2009117656A9 Capsid-incorporated antigen for novel adenovirus vaccine |
| 02/25/2010 | WO2009114702A3 Recombinant production of authentic human proteins using human cell expression systems |
| 02/25/2010 | US20100049491 Method and System for Optimizing Minigenes and Peptides Encoded Thereby |
| 02/25/2010 | US20100048878 Human gene |
| 02/25/2010 | US20100048698 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 02/25/2010 | US20100048683 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/25/2010 | US20100048672 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 02/25/2010 | US20100048458 Tribonectins |
| 02/25/2010 | US20100047838 Yeast genes that affect viral replication |
| 02/25/2010 | US20100047809 Pca3, pca3 genes, and methods of use |
| 02/25/2010 | US20100047315 protective coating, spray coating; drug delivery; cardiovascular disorders |
| 02/25/2010 | US20100047285 Anticancer agents using verotoxin variants |
| 02/25/2010 | US20100047274 Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alpha-virus-induced encephalitides |
| 02/25/2010 | US20100047267 Staphylococcus aureus proteins and nucleic acids |
| 02/25/2010 | US20100047265 Active antiangiogenic therapy |
| 02/25/2010 | US20100047208 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 02/25/2010 | US20100047179 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 02/25/2010 | CA2734917A1 Heterogeneous polymeric micelles for intracellular delivery |
| 02/25/2010 | CA2734892A1 Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase |
| 02/25/2010 | CA2734838A1 T cell receptors and related materials and methods of use |
| 02/24/2010 | EP2156831A1 Augmented Cognitive Training |
| 02/24/2010 | EP2155895A2 Methods and uses related to rhbdl4 |
| 02/24/2010 | EP2155878A2 A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 02/24/2010 | EP2155874A2 Fusion proteins of collagen-binding domain and parathyroid hormone |
| 02/24/2010 | EP2155772A1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 02/24/2010 | EP2155206A1 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide |
| 02/24/2010 | EP2155164A1 Self-precipitating pharmaceutical formulations for the modified release of active principle |
| 02/24/2010 | EP2154969A2 Treatment of synucleinopathies |
| 02/24/2010 | EP1725267B1 Enzyme-prodrug therapy for prosthetic joint repair |
| 02/24/2010 | EP1687032B1 Pharmaceutical composition for treating unresectable, locally advanced pancreatic cancer (lapc). |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1200607B1 Tet repressor-based transcriptional regulatory proteins |
| 02/24/2010 | EP0861261B9 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 02/24/2010 | CN101654673A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654672A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN100591762C Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/24/2010 | CN100591360C New application of chromaffin cell of adrenal medulla or opium peptide energy cell |
| 02/24/2010 | CN100591359C Lentiviral vector-mediated gene transfer and uses thereof |
| 02/23/2010 | US7667030 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease |
| 02/23/2010 | US7667027 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β) |
| 02/23/2010 | US7667020 Nucleotide sequence coding receptor protein for detecting moderator of autoimmune disease; treat, prevent, or delay a tissue proliferation-associated disorder as rheumatoid arthritis and multiple sclerosis |
| 02/23/2010 | US7667015 Genetic engineering; induce immunology response; biodrug as anticarcinogenic agents, for pancreatic cancer |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667005 Polypeptide, novel DNA and novel antibody |
| 02/23/2010 | US7666999 Neutral amino acid transporter and gene thereof |
| 02/23/2010 | US7666984 Consisting of the amino acid sequence ALFDGDPHL, the peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases |
| 02/23/2010 | US7666853 siRNA targeting connective tissue growth factor (CTGF) |
| 02/23/2010 | US7666852 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide |
| 02/23/2010 | US7666850 obtaining an epithelial cell sample suspected of being tumorigenic; identifying cells that have shed a 120-130 kD fragment of alpha -dystroglycan, presence of the fragment indicates that such cells are tumorigenic; contacting cell with a transfection agent containing a mammal dystroglycan gene |
| 02/23/2010 | US7666849 Ribosome structure and protein synthesis inhibitors |
| 02/23/2010 | US7666675 Hair follicle stem cells for use in the treatment of nervous system disorders and cell therapy |
| 02/23/2010 | US7666672 Neural stem cell culture for prevention and treatment of brain and nervous sytem disorders |
| 02/23/2010 | US7666669 Polypeptide |
| 02/23/2010 | US7666640 DNA sequences for the expression of alloproteins |
| 02/23/2010 | US7666639 Plant deoxyribonucleoside kinase enzymes and their use |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666613 psychiatric disorders; serine protease; genetic engineering; schizophrenia |
| 02/23/2010 | US7666586 Such as urinary bladder tissue; immunoassays |
| 02/23/2010 | US7666412 Methods for the treatment of neoplastic disorders with anti-caveolin agents |
| 02/23/2010 | US7666405 Deleted adenovirus vectors and methods of making and administering the same |
| 02/23/2010 | US7666404 Glanders/meliodosis vaccines |
| 02/23/2010 | CA2389743C Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 02/23/2010 | CA2355834C Human akt-3 |
| 02/23/2010 | CA2315277C Pharmaceutical compositions containing the long pentraxin ptx3 |
| 02/18/2010 | WO2010019914A2 Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre |
| 02/18/2010 | WO2010019847A2 Aptamer inhibition of thrombus formation |
| 02/18/2010 | WO2010019276A2 Method and formulation for treating adverse biological conditions |
| 02/18/2010 | WO2010018583A1 Toll-like receptor 9 agonists for the treatment of anxiety-related disorders and inflammatory disorders |
| 02/18/2010 | WO2010017962A1 Modified thromboxane a2 receptor promoter sequence |
| 02/18/2010 | WO2009129523A3 Compositions and methods for nucleic acid delivery |
| 02/18/2010 | WO2009120801A3 Ikki inhibitor therapies and screening methods, and related ikki diagnostics |
| 02/18/2010 | WO2009058970A3 A novel gene therapy approach for treating the metabolic disorder obesity |
| 02/18/2010 | US20100041868 Conserved neisserial antigens |
| 02/18/2010 | US20100041743 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 02/18/2010 | US20100041739 Transfection Reagent |
| 02/18/2010 | US20100041605 Use of VEGF-C or VEGF-D in Reconstructive Surgery |
| 02/18/2010 | US20100041151 Compositions and methods for treating lysosomal storage disease |
| 02/18/2010 | US20100041141 Methods and compositions relating to improved lentiviral vectors and their applications |
| 02/18/2010 | US20100041136 Connective Tissue Growth Factor-2 |
| 02/18/2010 | US20100041075 Tuberculosis Diagnostic Test |
| 02/18/2010 | US20100041028 Zinc finger binding domains for GNN |
| 02/18/2010 | US20100040643 Flavivirus immunogens and methods of use |
| 02/18/2010 | US20100040580 Freeze-dried composition of inactivated virus envelope with membrane fusion activity |